Aug. 15, 2008 -- For the first time, a major study shows that currently available inhaled medications can slow the deadly loss of lung function in COPD -- chronic obstructive pulmonary disease.
It takes a lot to slow a woman like Brenda Cunningham down. Even after being diagnosed with COPD, a severe lung disease that makes it difficult to move air in and out of her lungs, she refuses to settle down.
Main Category: Respiratory / Asthma Also Included In: Water - Air Quality / Agriculture Article Date: 11 Aug 2008 A weather alert service run by the UK's Meteorological Office that forecasts when weather is ...
Objective : To compare the effects of initial maintenance therapy with fluticasone 250 g plus salmeterol 50 g in a single inhaler versus other inhaled medications on exacerbation risks and treatment costs among ...
When my grandmother was alive, the 4th of July was one of my favorite holidays. As we sat on the front lawn eating savory barbecue and home-made potato salad, we could hardly wait for darkness to settle in so ...
RESEARCH TRIANGLE PARK, N.C. BioMarck Pharmaceuticals, Ltd. announced today that it has initiated the Phase 2 clinical development program of BIO-11006 Inhalation Solution, a novel treatment for chronic ...
Nycomed Canada Inc. today announced a licensing agreement with Chiesi Farmaceutici SpA to market Atimos , a treatment anticipated to be indicated for asthma and Chronic Obstructive Pulmonary Disease .
Editor's Choice Main Category: Respiratory / Asthma Also Included In: Clinical Trials / Drug Trials Article Date: 14 Jun 2008 - 0:00 PDT The worsening of symptoms in patients with chronic obstructive pulmonary ...
In people suffering from chronic obstructive pulmonary disease , the expectorant carbocisteine seems to help slow worsening of symptoms, Chinese researchers report.
Main Category: Respiratory / Asthma Article Date: 10 Jun 2008 - 3:00 PDT Leading UK experts in chronic obstructive pulmonary disease are calling for healthcare professionals to place greater emphasis on the ...
RDATE:04062008 London -- Although the inhaled delivery of drugs has major advantages over other methods of administration, inhaler devices are often difficult to use and can indirectly have a negative impact on ...
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launches of emerging therapies, especially the long-acting beta2 ...
Previous research has linked a class of asthma drugs known as long-acting beta agonists to increased risk of adverse respiratory-related events or death in patients with COPD .
A newly published study presents data demonstrating that patients with Chronic Obstructive Pulmonary Disease , including emphysema and chronic bronchitis, experienced markedly improved bronchodilation and ...
A new study suggests people with chronic obstructive pulmonary disease can stay out of the hospital - and possibly live longer--if they participate in a low-level management program.
Main Category: Respiratory / Asthma Also Included In: Clinical Trials / Drug Trials Article Date: 21 May 2008 Laboratorios Almirall, S.A. and Forest Laboratories, Inc.
A new study has found that patients with chronic obstructive pulmonary disease who are at high risk for hospitalization or emergency room visits from exacerbations or complications benefit from simple ...
